DAIC

APRIL 18, 2024

"We're further differentiating ourselves by using technology to supercharge our cardiac VBC model," said Karoo Health CEO and Cofounder Ian Koons. Seamlessly integrating dedicated on-site and virtual care teams with its Kohere.ai Karoo Health is a pioneer in the value-based healthcare services market, which is estimated at USD $1.63

Technology 105

Technology Outcomes Cardiovascular Disease 105

Frontiers in Cardiovascular Medicine

AUGUST 11, 2024

BackgroundRecently, the use of telemedicine technology has increased due to the Covid-19 pandemic. Cardiovascular diseases management is one of the areas that has benefited from using this technology. The results showed that teleconsultation via telephone and videoconferencing were the most common used technologies.

COVID-19 52

COVID-19 Technology Cardiovascular Disease Article 52

DAIC

JUNE 4, 2024

Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. The CaRi-Heart technology is in clinical use in the UK, European Union, and Australia.

Technology 116

Technology Heart Attack Heart attacks Coronary Artery Disease 116

American College of Cardiology

JANUARY 10, 2025

Assisted reproductive technology (ART) does not appear to be significantly associated with increased long-term risk of cardiovascular diseases in women, according to a meta-analysis of 10 studies comprised nearly 37 million participants.

Technology 65

Technology Cardiovascular Disease Article 65

DAIC

JANUARY 3, 2024

milla1cf Wed, 01/03/2024 - 12:09 January 3, 2024 — iRhythm Technologies, Inc. , The EU MDR is arguably one of the most stringent regulatory frameworks for product approvals globally that ensures medical devices meet the rigorous standards for healthcare technologies,” said Quentin Blackford, iRhythm President and Chief Executive Officer.

Technology 98

Technology Certification Arrhythmia Electrocardiogram 98

DAIC

JANUARY 18, 2024

Highlights from "Addressing Structural Racism Through Public Policy Advocacy: A Policy Statement from the American Heart Association" include: - During the past few years, the largest increases in cardiovascular disease deaths were among Asian, Black and Hispanic adults in the U.S. is tied to structural discrimination. -

Cardiovascular Disease 109

Cardiovascular Disease Health Disparities Education Public Health 109

Science Daily - Heart Disease

JULY 25, 2024

3D-printed blood vessels, which closely mimic the properties of human veins, could transform the treatment of cardiovascular diseases.

Outcomes 121

Outcomes Technology Cardiovascular Disease 121

HCPLive

SEPTEMBER 25, 2024

A Q&A with Nihar Desai, MD, on the PROMPT-Lipid trial and the potential of advancing technology for improving patient care in pragmatic ways.

Technology 52

Technology Cardiovascular Disease Patient Care 52

Frontiers in Cardiovascular Medicine

FEBRUARY 15, 2024

Background With the rapid development of technology, artificial intelligence (AI) has been widely used in the diagnosis and prognosis prediction of a variety of diseases, including cardiovascular disease. Facts have proved that AI has broad application prospects in rapid and accurate diagnosis.

Cardiovascular Disease 64

Cardiovascular Disease Article Research Cardiovascular Imaging 64

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

Recently, the use of assisted reproductive technology (ART) has rapidly increased. Moreover, emerging evidence suggests an increased risk of cardiovascular disease (CVD) in offspring conceived using ART. As a result, an increasing number of people are concerned about the safety of offspring produced through ART.

Technology 59

Technology Cardiovascular Disease Risk Factors 59

DAIC

JANUARY 17, 2024

Christian Tesche (Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina and Department of Cardiology, Munich University Clinic, Ludwig-Maximilian-University).

Technology 111

Technology Coronary Artery Disease Cardiovascular Disease Cardiovascular Imaging 111

International Journal of Cardiovascular Sciences

MARCH 27, 2025

This thematic issue aims to gather innovative research on the use of AI in the diagnosis, treatment, and monitoring of cardiovascular diseases, fostering advancements in precision medicine and healthcare efficiency.

Article 52

Article Innovation Education Research 52

DAIC

MAY 10, 2024

milla1cf Fri, 05/10/2024 - 08:17 May 10, 2024 — With cardiovascular disease being a leading cause of mortality worldwide, Vivalink , a leading provider of digital healthcare solutions, announces the launch of its comprehensive technology solution designed for Mobile Cardiac Telemetry (MCT) and Holter monitoring.

Technology 105

Technology Arrhythmia Heart Rhythm Cardiovascular Disease 105

Frontiers in Cardiovascular Medicine

FEBRUARY 19, 2025

Cardiovascular diseases (CVDs), characterized by a high incidence rate and high mortality, have become the leading cause of death globally. CVDs include coronary heart disease, stroke, hypertension, and peripheral vascular diseases. In China, the death rate of CVDs ranks the first in all major diseases.

Myocardial Infarction 52

Myocardial Infarction Quality of Life Heart Transplant Ischemia 52

Med Page Today

DECEMBER 24, 2024

(MedPage Today) -- Use of assisted reproductive technology (ART) was not significantly associated with an increased long-term risk of cardiovascular diseases in women, according to a meta-analysis. European Heart Journal) A randomized trial in.

TAVR 90

TAVR Technology Cardiovascular Disease 90

Circulation

FEBRUARY 25, 2024

RNA therapeutics hold significant promise in the treatment of cardiovascular diseases. RNA-based therapies are becoming more common as a treatment modality for cardiovascular disease. mRNA technology may provide the platform for the expression of paracrine factors for myocardial protection and regeneration.

COVID-19 102

COVID-19 Cardiovascular Disease Blood Pressure Technology 102

DAIC

DECEMBER 5, 2024

Cleerly is dedicated to creating a new standard of care for heart disease by using FDA-cleared solutions powered by artificial intelligence. As we’ve seen with their recent Medicare and CPT I code approvals, this technology is both valuable and ready today in the fight against heart disease.”

Coronary Artery Disease 52

Coronary Artery Disease Medicare Technology Plaque 52

DAIC

JUNE 4, 2024

milla1cf Tue, 06/04/2024 - 20:54 June 4, 2024 — HeartFlow, a leader in cardiovascular healthcare technology, is pleased to announce a key Medicare policy development, which should allow for future expanded patient access to their Plaque Analysis product.

Medicare 104

Medicare Plaque Reimbursement Technology 104

Frontiers in Cardiovascular Medicine

APRIL 4, 2024

On this state of the art, we summarize the available literature on the effectiveness of virtual reality on various physical and psychological outcomes in patients with atherosclerotic cardiovascular disease.

Cardiovascular Disease 49

Cardiovascular Disease Cardiac Rehabilitation Interventional Cardiology Technology 49

Medical Xpress - Cardiology

FEBRUARY 22, 2024

Too often, the first sign of cardiovascular disease may be a major event like a heart attack, stroke or cardiac arrest.

Cardiac Arrest 98

Cardiac Arrest Heart Disease Heart Attack Heart attacks 98

DAIC

JULY 16, 2024

mtaschetta-millane Tue, 07/16/2024 - 09:59 July 16, 2024 — Arineta , a leader in advancing cardiovascular imaging solutions through cutting-edge technology, proudly announces the latest installation of its SpotLight Duo at Cardiovascular Consultants, Ltd. (CVC) CVC) in Arizona. sec per rotation.

Technology 105

Technology Heart Disease Cardiovascular Imaging Cardiovascular Disease 105

DAIC

MAY 14, 2024

The collaboration seeks to provide access to emerging technologies, like Medis QFR, while also reducing complexity in the cath lab to improve the operating environment for clinicians.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

DAIC

JUNE 14, 2024

Positron joins forces with the coalitions founding members, Bracco Diagnostics , CDL Nuclear Technologies and Siemens Healthcare who have come together to promote federal policies that advance health outcomes for patients with cardiovascular disease and improve the availability of cardiac PET diagnostics throughout the United States.

Reimbursement 105

Reimbursement Technology Innovation Education 105

American College of Cardiology

DECEMBER 18, 2023

In 2023, we continued to see advances in global health technology. These technologies provide a means to prevent, diagnose and treat cardiovascular disease and may also hold the keys to addressing health equity and improving clinician well-being.

Technology 75

Technology Cardiovascular Disease Article 75

DAIC

FEBRUARY 10, 2025

Early detection and intervention are essential in addressing cardiovascular diseases, and Eko is dedicated to providing accessible and scalable technologies that empower healthcare providers while improving patient care globally."

Research 64

Research Innovation Pulmonary Hypertension 64

DAIC

FEBRUARY 24, 2025

Cardiovascular disease (CVD) remains the leading cause of death in the U.S. By enabling the decisive shift from a reactive to a proactive cardiology model, this technology doesnt just improve patient outcomes it is also helping keep cardiovascular care sustainable and affordable. That future isnt decades away.

Hospital 52

Hospital Cardiovascular Disease Heart Failure Heart Attack 52

DAIC

JULY 18, 2024

About Kardia 12L ECG and KAI 12L AI Technology Kardia 12L ECG System combines the power of KAI 12L's AI technology and the pocket-sized Kardia 12L, to enable faster, easier detection of life-threatening cardiac conditions.

Reimbursement 105

Reimbursement Technology Electrocardiogram Medicaid 105

DAIC

FEBRUARY 28, 2024

The new scientific statement, “Use of Artificial Intelligence in Improving Outcomes in Heart Disease,” comes amid intense attention on AI as a way to improve cardiovascular disease prevention, detection, diagnosis and treatment. to ensure safety and effectiveness to mitigate harm as technologies rapidly evolve.

Best Practices 111

Best Practices Technology Cardiovascular Disease Stroke 111

Circulation

JANUARY 15, 2025

The use of assisted reproductive technology (ART) is growing, both to assist individuals with infertility and for fertility preservation. Individuals with cardiovascular disease (CVD), or risk factors for CVD, are increasingly using ART. Circulation, Ahead of Print.

Technology 49

Technology Risk Factors Cardiovascular Disease Circulation 49

DAIC

JULY 25, 2024

The IVI is working towards a transition to a new kind of wellness and health system fueled and empowered by digital technologies. This concept, reported the company, is about using technology to develop preventative approaches that are 10 times more impactful than the current available solution.

Technology 105

Technology Exercise Innovation Quality of Life 105

DAIC

JUNE 18, 2024

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. 1 To date, interventional treatment of coronary artery disease with drug-eluting stents has been able to establish flow angiographically. of the U.S. population.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

Journal of the American Heart Association

JANUARY 16, 2024

Cardiovascular diseases (CVDs) remain the leading cause of death and disability worldwide. Digital health technologies are important public health interventions for addressing the burden of cardiovascular disease. Journal of the American Heart Association, Volume 13, Issue 2 , January 16, 2024.

Technology 40

Technology Innovation Public Health Cardiovascular Disease 40

DAIC

DECEMBER 9, 2023

Dr. Aditya Sharma Dr. Sharma is board certified in internal medicine, cardiovascular disease, and interventional cardiology, having completed both residency and fellowship programs at George Washington University - School of Medicine and Hospital. Case review of use of the ACIST CVi Contrast Delivery System in high risk patient.

Webinar 105

Webinar Interventional Cardiology Best Practices Risk Factors 105

DAIC

OCTOBER 1, 2024

Food and Drug Administration (FDA) for its PlaqueIQ imaging analysis software to help physicians diagnose cardiovascular disease (CVD). Elucid has announced it received 510(k) clearance from the U.S. Hafiane, Vulnerable plaque, characteristics, detection, and potential therapies , J. Cardiovasc. 6 (3) (2019).

Cardiovascular Disease 52

Cardiovascular Disease Plaque Quality of Life Myocardial Infarction 52

DAIC

JULY 18, 2024

Kolossváry added, “The PRE-VUE registry will empower us to see the true additive value of CT-derived, histologically validated plaque volumes in predicting future adverse cardiovascular events.” 2017 23, April 2020; Available from: [link]. Hafiane, Vulnerable plaque, characteristics, detection, and potential therapies , J.

Plaque 105

Plaque Heart Attack Heart attacks Cardiovascular Disease 105

Frontiers in Cardiovascular Medicine

JUNE 28, 2024

Transesophageal Echocardiography (TEE) is an important imaging method for the evaluation of cardiac structure and function, and it holds significant value in the clinical management of cardiovascular diseases.

Article 75

Article Technology Cardiovascular Disease 75

DAIC

JULY 10, 2024

In a room of 20 people, it’s likely that about 10 of them, or half, will presently have some form of cardiovascular disease (CVD). CVD is among the most prevalent diseases in the U.S., This includes artificial intelligence (AI), remote monitoring, virtual care, and other emerging technological advancements.

Technology 106

Technology Best Practices AFIB Patient Care 106